Roadshow alert! Join Med-Tech World in London this May
The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by Melbourne, Australia based Montu Group, leveraging their newly launched premium medical brand Circle.
The transaction represents the first production run of Aleafia Health’s newly launched international white label production service, which leverages the Company’s proven formulas and international distribution channels.
“We are pleased to leverage our established Australian sales channel and new relationship with Montu Group in this fast growing medical cannabis market. With the strength of our existing local distribution network and investments, we are increasing our Australian footprint, as we also deploy our cannabis education platform and clinic operations expertise,” said Aleafia Health CEO Geoffrey Benic. “White label production also represents a new opportunity for us and highlights the strength of our value-added production ecosystem.”
“The launch of our medical cannabis brand Circle in Australia is strengthened by Aleafia Health’s proven product expertise derived from their proprietary set of over 10 million patient-related data points,” said Montu Group Managing Director Christopher Strauch. “Australia is a core pillar of our international expansion strategy, as one of the leading and fastest growing medical cannabis markets in the world. This relationship marks an important milestone in supporting our growing network of doctors to access high quality cannabis products.”
All necessary import permits from the Australian Department of Health have been secured, and the shipment is expected to be completed in late 2019, following receipt of necessary Health Canada export permits.
About Medical Cannabiz World:
In November 2019, Medical Cannabiz World opened its doors to the medicinal cannabis industry, supported by the Maltese government’s commitment to legislation for this high growth sector. Medical Cannabiz World summit 2020 will focus on the Malta medical cannabis industry as well as global opportunities in the sector, attracting investors, medical researchers, policy makers and entrepreneurs looking to forge exciting new opportunities.